IMMUCELL CORPORATION - COMMON STOCK
5,0200
18-февраля-25 16:00:22
15 мин. задержка
Акции
-0,0300
-0,59%
Сегодняшний диапазон
5,0000 - 5,2519
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023
04 май 2023 06:30:23 Источник Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023
05 апр 2023 16:05:35 Источник Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022
21 фев 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022
15 фев 2023 11:55:13 Источник Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022
09 янв 2023 16:05:06 Источник Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022
21 ноя 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2022
10 ноя 2022 16:05:02 Источник Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Third Quarter of 2022
05 окт 2022 06:30:00 Источник Nasdaq GlobeNewswire
-
ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference
14 сен 2022 17:01:34 Источник Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2022
11 авг 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022
04 авг 2022 06:30:00 Источник Nasdaq GlobeNewswire
-
ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain®
27 июл 2022 20:05:00 Источник Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022
07 июл 2022 06:30:00 Источник Nasdaq GlobeNewswire
-
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
19 май 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022
12 май 2022 16:05:02 Источник Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022
10 май 2022 10:00:00 Источник Nasdaq GlobeNewswire
-
UPDATE -- Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
05 май 2022 13:17:59 Источник Nasdaq GlobeNewswire
-
Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
05 май 2022 11:17:08 Источник Nasdaq GlobeNewswire
-
ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022
11 апр 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2021
22 фев 2022 16:05:00 Источник Nasdaq GlobeNewswire